<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lin H</submitter><funding>National Natural Science Foundation of China</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>2648-2659</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8632971</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(12)</volume><pubmed_abstract>The IL-6-STAT3 axis is critically involved in inflammation-associated carcinogenesis (IAC). How this axis is regulated to modulate IAC remains unknown. Here, we show that the plasma membrane-associated E3 ubiquitin ligase MARCH3 negatively regulates STAT3 activation triggered by IL-6, as well as another IL-6 subfamily member, Oncostatin M (OSM). MARCH3 is associated with the IL-6 receptor α-chain (IL-6Rα) and its coreceptor gp130. Biochemical experiments indicated that MARCH3 mediates the polyubiquitination of IL-6Rα at K401 and gp130 at K849 following IL-6 stimulation, leading to their translocation to and degradation in lysosomes. MARCH3 deficiency increases IL-6- and OSM-triggered activation of STAT3 and induction of downstream effector genes in various cell types. MARCH3 deficiency enh</pubmed_abstract><journal>Cellular &amp; molecular immunology</journal><pubmed_title>The membrane-associated E3 ubiquitin ligase MARCH3 downregulates the IL-6 receptor and suppresses colitis-associated carcinogenesis.</pubmed_title><pmcid>PMC8632971</pmcid><funding_grant_id>31830024</funding_grant_id><pubmed_authors>Zeng LW</pubmed_authors><pubmed_authors>Feng L</pubmed_authors><pubmed_authors>Cui KS</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Zhang LX</pubmed_authors><pubmed_authors>Sun YH</pubmed_authors><pubmed_authors>Lin H</pubmed_authors><pubmed_authors>Xu WH</pubmed_authors><pubmed_authors>Shu HB</pubmed_authors><pubmed_authors>Gao D</pubmed_authors></additional><is_claimable>false</is_claimable><name>The membrane-associated E3 ubiquitin ligase MARCH3 downregulates the IL-6 receptor and suppresses colitis-associated carcinogenesis.</name><description>The IL-6-STAT3 axis is critically involved in inflammation-associated carcinogenesis (IAC). How this axis is regulated to modulate IAC remains unknown. Here, we show that the plasma membrane-associated E3 ubiquitin ligase MARCH3 negatively regulates STAT3 activation triggered by IL-6, as well as another IL-6 subfamily member, Oncostatin M (OSM). MARCH3 is associated with the IL-6 receptor α-chain (IL-6Rα) and its coreceptor gp130. Biochemical experiments indicated that MARCH3 mediates the polyubiquitination of IL-6Rα at K401 and gp130 at K849 following IL-6 stimulation, leading to their translocation to and degradation in lysosomes. MARCH3 deficiency increases IL-6- and OSM-triggered activation of STAT3 and induction of downstream effector genes in various cell types. MARCH3 deficiency enh</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-25T20:50:59.866Z</modification><creation>2025-04-06T08:33:41.591Z</creation></dates><accession>S-EPMC8632971</accession><cross_references><pubmed>34785732</pubmed><doi>10.1038/s41423-021-00799-1</doi></cross_references></HashMap>